It is thus intriguing to hypothesize that NKCEs, simultaneously engaging NKG2D, 2B4, and a tumor-associated antigen, could induce a more potent NK cell activation and more robust anti-tumor activity. This evidence concerns the gene KLRK1 and neoplasm.